NeuBase Therapeutics, Inc.
NBSEDelisted May 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173281
NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding NeuBase Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 16.1K | 0 | −16.1K (−100.0%) |
| Value | $4.95K | $0 | −$4.95K (−100.0%) |
New holders (0)
Institutions that held NeuBase Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (2)
Institutions that held NeuBase Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Baader Bank INC | 16,089 | $4.95K |
| Advisor Group Holdings, Inc. | 1 | $0 |